USAQ — QHSLab Income Statement
0.000.00%
Last trade - 00:00- $3.27m
- $4.69m
- $2.13m
- 58
- 67
- 75
- 75
Annual income statement for QHSLab, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.125 | 1.41 | 1.24 | 1.41 | 2.13 |
| Cost of Revenue | |||||
| Gross Profit | 0.05 | 0.671 | 0.62 | 0.794 | 1.36 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.421 | 1.94 | 1.81 | 1.65 | 1.93 |
| Operating Profit | -0.296 | -0.524 | -0.563 | -0.24 | 0.206 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.327 | -0.77 | -0.996 | -0.468 | -0.259 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.327 | -0.77 | -0.996 | -0.468 | -0.259 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.327 | -0.77 | -0.996 | -0.468 | -0.259 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.327 | -0.77 | -0.996 | -0.468 | -0.259 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.049 | -0.095 | -0.11 | -0.05 | -0.025 |